IP Library Granted Patent US 11,364,112
Granted Patent B2
US 11,364,112 · App. 17/073,896 · Granted Jun 21, 2022

Intraocular lenses having zone-by-zone step height control

Inventors: Xin Hong (Fort Worth, TX); Shinwook Lee (Arlington, TX)
Assignee: Alcon Inc.
A61F2/1656A61F2/1616A61F2/1618A61F2/1654G02B3/08G02B27/0012G02B27/4205G02C7/04G02C7/044A61F2002/1683G02C2202/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,364,112
App. No.
17/073,896
Granted
Jun 21, 2022
Kind
B2
Abstract

A method and system provide an ophthalmic device. The ophthalmic device includes an ophthalmic lens having anterior surface, a posterior surface and at least one diffractive structure including a plurality of zones. The at least one diffractive structure is for at least one of the anterior surface and the posterior surface. Each zone includes at least one echelette having a least one step height. The step height(s) are individually optimized for each zone. To compensate chromatic aberration of eye from distance to a range of vision, a greater than 2π phase step height may be employed and the step height(s) folded by a phase, which is an integer multiple of two multiplied by π. Hence chromatic aberration of eye may be compensated to improve vision from distance to near.

Claims (10)

1. A method for fabricating an intraocular lens (IOL) having at least one focal length, the method comprising:

designing at least one diffractive structure including a plurality of zones for incorporation into at least one of an anterior surface and a posterior surface of the intraocular lens, each of the plurality of zones including at least one echelette having at least one step height, the step of designing the at least one diffractive structure further comprising:

individually optimizing each zone of the plurality of zones to provide at least one optimized step height having at least one optimized phase in each zone of the plurality of zones; and

folding the at least one optimized step height in each zone of the plurality of zones by a phase to provide the at least one step height in each zone of the plurality of zones if the optimized step in each zone of the plurality of zones exceeds two multiplied by π, the phase being an integer multiple of two multiplied by π; and

fabricating the intraocular lens using the at least one step height of each zone of the plurality of zones for the at least one diffractive structures;

wherein, after folding the at least one optimized step height in each zone of the plurality of zones by a phase, the at least one step in each zone of the plurality of zones is not more than two multiplied by π to compensate for chromatic aberration for a range of vision;

wherein the at least one focal length is a plurality of focal lengths and wherein the step of individually optimizing each zone further includes individually optimizing each zone for at least a portion of the plurality of focal lengths.

2. The method of claim 1 wherein the at least one diffractive structure is incorporated into the anterior surface.

3. The method of claim 1 wherein the at least one diffractive structure is incorporated into the posterior surface.

4. The method of claim 1 wherein the step of individually optimizing each zone further includes individually optimizing each zone for a plurality of target positions.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2021
From: HONG, XIN; LEE, SHINWOOK
To: ALCON RESEARCH, LTD.
Reel/Frame 055992/0195 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2021
From: ALCON RESEARCH, LTD.
To: NOVARTIS AG
Reel/Frame 055992/0497 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2021
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 055992/0588 →
Continuity (3)
Division 15807771 · Nov 9, 2017
Provisional Application 62427241 · Nov 29, 2016
Related Publication 20210030532A1 · Feb 4, 2021
Cited By (1)
US 12,433,740